Analyst Ratings for Ironwood Pharmaceuticals (IRWD) [Neutrals]
IRWD Rating Summary
IRWD Price Target Summary
- Highest: $22.00 (JMP Securities)
- Lowest: $10.50 (TD Cowen)
- Average: $17.08
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$17.08 (+100.7%)
* Over Last 12-Mos
Rating Score: 5.2 / 10 Percentile Rank: 57%
Rating Score: 5.2 / 10 Percentile Rank: 57%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
7/10/2019 | Credit Suisse » Updated 11/6/2020 |
Martin Auster | New Coverage | Neutral (N/A) |
12.00 (11.00) |
10.18 (8.51) |
-16.4% | Details |
3/27/2019 | Morgan Stanley » Updated 10/12/2021 |
David Lebowitz | Upgrade | Equalweight (Underweight) |
14.00 (13.00) |
13.75 (8.51) |
-38.11% | Details |